Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

KALVKALV
Showing 8 of 27 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in KALVISTA PHARMACEUTICALS INC

CITADEL ADVISORS LLC previously held 0 shares of KALV (KALVISTA PHARMACEUTICALS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1.5M

Total Shares Change

-127,249

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$27.00
0
2026-Q1
Increased
97,726
+158.8%
$2M0.0%$15.61
42
2025-Q4
New
37,761
-
$609,8410.0%$15.68
34
2025-Q3
Exited
0
-100.0%
$00.0%$12.21
0
2025-Q2
New
15,841
-
$179,0830.0%$11.41
35
2025-Q1
Exited
0
-100.0%
$00.0%$11.93
0
2024-Q4
Increased
136,493
+7.3%
$1.2M0.0%$8.39
27
2024-Q3
Increased
127,249
+576.1%
$1.5M0.0%$12.34
41

Other major holders of KALV: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, Capital World Investors, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used